| 5-amino-1MQ 10mg | | 1.8 | Nov 10, 2026 | PDF |
| Acetyl Octapeptide-3 (Snap-8) | 868844-74-0 | 1.8 | Nov 10, 2026 | PDF |
| AOD-9604 | 221231-10-3 | 1.8 | Nov 10, 2026 | PDF |
| BPC-157 | 137525-51-0 | 1.8 | Nov 10, 2026 | PDF |
| BPC-157 5mg / TB-500 5mg (blend) | | 1.8 | Nov 10, 2026 | PDF |
| Bremelanotide | 189691-06-3 | 1.8 | Nov 10, 2026 | PDF |
| Cagrilintide 5mg | | 1.8 | Nov 10, 2026 | PDF |
| CJC-1295 (no DAC) 5mg / Ipamorelin 5mg (blend) | | 1.8 | Nov 10, 2026 | PDF |
| CJC-1295 W/ DAC 2mg | | 1.8 | Nov 10, 2026 | PDF |
| CJC-1295 W/O DAC (Mod GRF 1-29) 2mg | | 1.8 | Nov 10, 2026 | PDF |
| Delta Sleep-Inducing Peptide | 62568-57-4 | 1.8 | Nov 8, 2026 | PDF |
| Dihexa 10mg | | 1.8 | Nov 10, 2026 | PDF |
| Epitalon | 307297-39-8 | 1.8 | Nov 10, 2026 | PDF |
| Fragment 176-191 2MG | | 1.8 | Nov 10, 2026 | PDF |
| GHK-Cu 50mg | | 1.8 | Nov 10, 2026 | PDF |
| GHRP-2 | 158861-67-7 | 1.8 | Nov 10, 2026 | PDF |
| GHRP-6 | 87616-84-0 | 1.8 | Nov 10, 2026 | PDF |
| Glow Blend 70mg (GHK-CU 50mg, BPC-157 10mg, TB-500 10mg) | | 1.8 | Nov 10, 2026 | PDF |
| Glutathione 1500mg | | 1.8 | Nov 10, 2026 | PDF |
| Glutathione 600mg | | 1.8 | Nov 10, 2026 | PDF |
| Hexarelin | 140703-51-1 | 1.8 | Nov 10, 2026 | PDF |
| IGF-1 LR3 1mg | | 1.8 | Nov 10, 2026 | PDF |
| Ipamorelin | 170851-70-4 | 1.8 | Nov 10, 2026 | PDF |
| Kisspeptin-10 | 374675-21-5 | 1.8 | Nov 10, 2026 | PDF |
| Klow Blend 80mg (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) | | 1.8 | Nov 10, 2026 | PDF |
| KPV 5mg | | 1.8 | Nov 10, 2026 | PDF |
| LL-37 | 154947-66-7 | 1.8 | Nov 10, 2026 | PDF |
| Mazdutide | 2259884-03-0 | 1.8 | Nov 10, 2026 | PDF |
| Melanotan II | 121062-08-6 | 1.8 | Nov 10, 2026 | PDF |
| MGF (Mechano Growth Factor) 2mg | | 1.8 | Nov 10, 2026 | PDF |
| MOTS-c 10mg | | 1.8 | Nov 10, 2026 | PDF |
| NAD+ 500mg | | 1.8 | Nov 10, 2026 | PDF |
| Oxytocin | 50-56-6 | 1.8 | Nov 10, 2026 | PDF |
| Pinealon 10mg | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| RESEARCH USE ONLY · FORMULATION | | 1.8 | Nov 10, 2026 | PDF |
| Selank | 129954-34-3 | 1.8 | Nov 10, 2026 | PDF |
| Semaglutide | 910463-68-2 | 1.8 | Nov 10, 2026 | PDF |
| Semax | 80714-61-0 | 1.8 | Nov 10, 2026 | PDF |
| Sermorelin | 86168-78-7 | 1.8 | Nov 10, 2026 | PDF |
| Survodutide 10mg | | 1.8 | Nov 10, 2026 | PDF |
| TB-500 5mg (Thymosin Beta 4 Fragment) | | 1.8 | Nov 10, 2026 | PDF |
| Tesamorelin | 218949-48-5 | 1.8 | Nov 10, 2026 | PDF |
| Tesamorelin 10mg / Ipamorelin 2mg (blend) | | 1.8 | Nov 10, 2026 | PDF |
| Thymosin Alpha-1 | 62304-98-7 | 1.8 | Nov 10, 2026 | PDF |
| Thymosin Beta-4 | 77591-33-4 | 1.8 | Nov 10, 2026 | PDF |
| Tirzepatide | 2023788-19-2 | 1.8 | Nov 10, 2026 | PDF |
| Triptorelin | 57773-63-4 | 1.8 | Nov 10, 2026 | PDF |